168 related articles for article (PubMed ID: 20552256)
1. PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells.
Thiagarajan G; Ray A; Malugin A; Ghandehari H
Pharm Res; 2010 Nov; 27(11):2307-16. PubMed ID: 20552256
[TBL] [Abstract][Full Text] [Related]
2. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
[TBL] [Abstract][Full Text] [Related]
4. Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation.
Vijayalakshmi N; Ray A; Malugin A; Ghandehari H
Bioconjug Chem; 2010 Oct; 21(10):1804-10. PubMed ID: 20836544
[TBL] [Abstract][Full Text] [Related]
5. Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.
Shen Y; Zhou Z; Sui M; Tang J; Xu P; Van Kirk EA; Murdoch WJ; Fan M; Radosz M
Nanomedicine (Lond); 2010 Oct; 5(8):1205-17. PubMed ID: 21039198
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
7. G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
Goldberg DS; Vijayalakshmi N; Swaan PW; Ghandehari H
J Control Release; 2011 Mar; 150(3):318-25. PubMed ID: 21115079
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.
Fox ME; Guillaudeu S; Fréchet JM; Jerger K; Macaraeg N; Szoka FC
Mol Pharm; 2009; 6(5):1562-72. PubMed ID: 19588994
[TBL] [Abstract][Full Text] [Related]
9. Poly(amidoamine) Dendrimer/Camptothecin Complex: From Synthesis to In Vitro Cancer Cell Line Studies.
Oledzka E; Paśnik K; Domańska I; Zielińska-Pisklak M; Piotrowska U; Sobczak M; Szeleszczuk Ł; Laskowska A
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985668
[TBL] [Abstract][Full Text] [Related]
10. Surface modified PAMAM dendrimers with gallic acid inhibit, cell proliferation, cell migration and inflammatory response to augment apoptotic cell death in human colon carcinoma cells.
Priyadarshi K; Shirsath K; Waghela NB; Sharma A; Kumar A; Pathak C
J Biomol Struct Dyn; 2021 Nov; 39(18):6853-6869. PubMed ID: 32752940
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug.
Xu Z; Zheng W; Yin Z
Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.
Singer JW; Bhatt R; Tulinsky J; Buhler KR; Heasley E; Klein P; de Vries P
J Control Release; 2001 Jul; 74(1-3):243-7. PubMed ID: 11489501
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
15. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
16. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
Cheng Y; Li M; Xu T
Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Combination Chemotherapy of Camptothecin and Floxuridine through Self-Assembly of Amphiphilic Drug-Drug Conjugate.
Hu M; Huang P; Wang Y; Su Y; Zhou L; Zhu X; Yan D
Bioconjug Chem; 2015 Dec; 26(12):2497-506. PubMed ID: 26497258
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activity of G3 PAMAM-NH₂ dendrimer-chlorambucil conjugate in human breast cancer cells.
Bielawski K; Bielawska A; Muszyńska A; Popławska B; Czarnomysy R
Environ Toxicol Pharmacol; 2011 Nov; 32(3):364-72. PubMed ID: 22004955
[TBL] [Abstract][Full Text] [Related]
19. Bendamustine-PAMAM Conjugates for Improved Apoptosis, Efficacy, and in Vivo Pharmacokinetics: A Sustainable Delivery Tactic.
Gothwal A; Khan I; Kumar P; Raza K; Kaul A; Mishra AK; Gupta U
Mol Pharm; 2018 Jun; 15(6):2084-2097. PubMed ID: 29195048
[TBL] [Abstract][Full Text] [Related]
20. Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo.
Du H; Huang Y; Hou X; Quan X; Jiang J; Wei X; Liu Y; Li H; Wang P; Zhan M; Ai X; Lu L; Yuan S; Sun L
Eur J Pharm Sci; 2018 Oct; 123():546-559. PubMed ID: 30118848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]